Insider Trades39 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 42,164 | $32.27 | $3.1B | -37.75% | +409.85% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Jun 30, 2026 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 40,000 | $36.21 | $3.1B | -37.75% | +409.85% | $1.4M | -3.54% | 10b5-1 | Stalk |
| Jun 26, 2026 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 1,434 | $46.86 | $3.1B | -37.75% | +409.85% | $67.2K | -0.85% | — | Stalk |
| Jun 24, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 68,256 | $41.21 | $3.1B | -37.75% | +409.85% | $2.8M | -0.11% | 10b5-1 | Stalk |
| Jun 17, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 273,337 | $39.27 | $3.1B | -37.75% | +409.85% | $10.7M | -2.17% | 10b5-1 | Stalk |
| Jun 15, 2026 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 5,237 | $27.67 | $3.1B | -37.75% | +409.85% | $144.9K | -3.78% | — | Stalk |
| Jun 11, 2026 | Sell | QURE | Kylie O'Keefe | Chief Customer & Strat Officer | 15,936 | $27.06 | $3.1B | -37.75% | +409.85% | $431.2K | -12.77% | — | Stalk |
| May 8, 2026 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 70,000 | $18.10 | $3.1B | -37.75% | +409.85% | $1.3M | -3.06% | 10b5-1 | Stalk |
| Mar 4, 2026 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 808 | $9.06 | $3.1B | -37.75% | +409.85% | $7.3K | -0.31% | — | Stalk |
| Mar 4, 2026 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 3,412 | $9.06 | $3.1B | -37.75% | +409.85% | $30.9K | -1.71% | — | Stalk |
| Mar 4, 2026 | Sell | QURE | Christian Klemt | Chief Financial Officer | 12,000 | $9.06 | $3.1B | -37.75% | +409.85% | $108.7K | -3.97% | — | Stalk |
| Mar 4, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 14,581 | $9.06 | $3.1B | -37.75% | +409.85% | $132.1K | -1.85% | — | Stalk |
| Mar 2, 2026 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 1,660 | $9.95 | $3.1B | -37.75% | +409.85% | $16.5K | -1.10% | — | Stalk |
| Mar 2, 2026 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 8,578 | $9.95 | $3.1B | -37.75% | +409.85% | $85.4K | -7.45% | — | Stalk |
| Mar 2, 2026 | Sell | QURE | Christian Klemt | Chief Financial Officer | 12,532 | $9.95 | $3.1B | -37.75% | +409.85% | $124.7K | -5.92% | — | Stalk |
| Mar 2, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 34,437 | $9.95 | $3.1B | -37.75% | +409.85% | $342.6K | -5.39% | — | Stalk |
| Feb 25, 2026 | Sell | QURE | Christian Klemt | Chief Financial Officer | 6,217 | $23.86 | $3.1B | -37.75% | +409.85% | $148.3K | -2.86% | — | Stalk |
| Feb 25, 2026 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 12,378 | $23.86 | $3.1B | -37.75% | +409.85% | $295.3K | -1.90% | — | Stalk |
| Sep 24, 2025 | Sell | QURE | Christian Klemt | Chief Financial Officer | 36,000 | $29.58 | $3.1B | -37.75% | +409.85% | $1.1M | +0.00% | 10b5-1 | Stalk |
| Sep 24, 2025 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 452,632 | $23.99 | $3.1B | -37.75% | +409.85% | $10.9M | +0.00% | 10b5-1 | Stalk |
| Jun 27, 2025 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 1,466 | $13.92 | $3.1B | -37.75% | +409.85% | $20.4K | -0.97% | — | Stalk |
| Jun 16, 2025 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 4,670 | $15.14 | $3.1B | -37.75% | +409.85% | $70.7K | -3.90% | — | Stalk |
| Mar 4, 2025 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 1,350 | $10.29 | $3.1B | -37.75% | +409.85% | $13.9K | -0.62% | — | Stalk |
| Mar 4, 2025 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 7,076 | $10.29 | $3.1B | -37.75% | +409.85% | $72.8K | -3.79% | — | Stalk |
| Mar 4, 2025 | Sell | QURE | Christian Klemt | Chief Financial Officer | 10,438 | $10.29 | $3.1B | -37.75% | +409.85% | $107.4K | -2.95% | — | Stalk |
| Mar 4, 2025 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 28,341 | $10.29 | $3.1B | -37.75% | +409.85% | $291.6K | -3.33% | — | Stalk |
| Feb 25, 2025 | Sell | QURE | Christian Klemt | Chief Financial Officer | 17,257 | $10.80 | $3.1B | -37.75% | +409.85% | $186.5K | -5.31% | — | Stalk |
| Feb 25, 2025 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 33,444 | $10.82 | $3.1B | -37.75% | +409.85% | $362.0K | -2.82% | — | Stalk |
| Dec 10, 2024 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 200,000 | $14.87 | $3.1B | -37.75% | +409.85% | $3.0M | +0.00% | 10b5-1 | Stalk |
| Dec 9, 2024 | Sell | QURE | Christian Klemt | Chief Financial Officer | 1,796 | $7.55 | $3.1B | -37.75% | +409.85% | $13.6K | -1.07% | — | Stalk |
| Dec 9, 2024 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 3,418 | $7.63 | $3.1B | -37.75% | +409.85% | $26.1K | -0.57% | — | Stalk |
| Jun 26, 2024 | Sell | QURE | Walid Abi-Saab | Chief Medical Officer | 1,447 | $4.36 | $3.1B | -37.75% | +409.85% | $6.3K | -1.24% | — | Stalk |
| Jun 17, 2024 | Sell | QURE | Christian Klemt | Chief Financial Officer | 1,611 | $4.80 | $3.1B | -37.75% | +409.85% | $7.7K | -0.97% | — | Stalk |
| Jun 17, 2024 | Sell | QURE | Pierre Caloz | Chief Operating Officer | 2,936 | $4.81 | $3.1B | -37.75% | +409.85% | $14.1K | -2.47% | — | Stalk |
| Jun 13, 2024 | Sell | QURE | Jeannette Potts | Chief Legal Officer | 4,781 | $4.98 | $3.1B | -37.75% | +409.85% | $23.8K | -4.95% | — | Stalk |
| Feb 26, 2024 | Sell | QURE | Pierre Caloz | Chief Operating Officer | 9,455 | $6.47 | $3.1B | -37.75% | +409.85% | $61.2K | -9.94% | — | Stalk |
| Feb 26, 2024 | Sell | QURE | Christian Klemt | Chief Financial Officer | 15,906 | $6.38 | $3.1B | -37.75% | +409.85% | $101.5K | -11.97% | — | Stalk |
| Feb 26, 2024 | Sell | QURE | Matthew C Kapusta | CEO, Managing Director | 27,904 | $6.35 | $3.1B | -37.75% | +409.85% | $177.2K | -5.95% | — | Stalk |
| Sep 18, 2023 | Sell | QURE | Ricardo Dolmetsch | President, R&D | 5,841 | $7.46 | $3.1B | -37.75% | +409.85% | $43.6K | -3.45% | — | Stalk |